Concord Drugs Ltd
₹83.93
(1.24%)
Mon, 01 Jun 2026, 03:58 pm
Health Technology
Pharmaceuticals: Major
24.5KConcord Drugs Share Price Live Chart
1 Day
(1.24%)
No Result Found
Summary
Market Cap
108.55
Net Profit
0.34
P/B
0.91
Sector P/E
33.76
P/E
91.41
EV/EBITDA
12.08
Debt/Equity (Industry)
0.24
Interest Cover (Industry)
9.79
ROCE (Industry)
14.04
RONW (Industry)
13.17
ROE
1
ROCE
4.94
Debt/Equity
0.54
EPS (TTM)
0.80
Dividend Yield
0
Book Value
36.82
Interest Cover
1.34
Analysis
all
- Concord Drugs is able to meet its short term (1 year) commitments with its holdings of cash and other short term assets.
- Concord Drugs is profitable, therefore cash runway is not a concern.
- Concord Drugs is profitable, therefore cash runway is not a concern.
- Debt is well covered by operating cash flow (26.1%, greater than 20% of total debt).
- Debt is covered by short term assets, assets are 6.2x debt.
- Unable to evaluate Concord Drugs's dividend yield against the bottom 25% of dividend payers as the company has not reported any payouts.
- Unable to evaluate Concord Drugs's dividend against the top 25% market benchmark as the company has not reported any payouts.
- Interest payments on debt are not well covered by earnings (EBIT is 1.4x annual interest expense, ideally 3x coverage).
- Concord Drugs's level of debt (42.1%) compared to net worth is high (greater than 40%).
- High level of physical assets or inventory.
Shareholding
| Shareholders | MAR 2026 | DEC 2025 | SEPT 2025 | JUN 2025 | MAR 2025 |
|---|---|---|---|---|---|
| Promoters | 54.39 | 54.39 | 54.39 | 54.39 | 54.39 |
| FII | 0 | 0 | 0 | 0 | 0 |
| DII | 0 | 0 | 0 | 0 | 0 |
| Public | 45.61 | 45.61 | 45.61 | 45.61 | 45.61 |
| Government | 0 | 0 | 0 | 0 | 0 |
Technical Analysis
Support and Resistance
| Type | R3 | R2 | R1 | PP | S1 | S2 | S3 |
|---|---|---|---|---|---|---|---|
| Classic | 104.93 | 93.95 | 88.94 | 82.97 | 77.96 | 71.99 | 61.01 |
| Fibonacci | 93.95 | 89.76 | 87.16 | 82.97 | 78.78 | 76.18 | 71.99 |
| Camarilla | 86.95 | 85.94 | 84.94 | 82.97 | 82.92 | 81.92 | 80.91 |
Pivots Level: Classic
R3
+21.96
104.93
R2
+10.98
93.95
R1
+5.97
88.94
S1
-5.01
77.96
S2
-10.98
71.99
S3
-21.96
61.01
Moving Average
Period
Value
10-EMA
81.69
20-EMA
81.54
30-EMA
81.20
50-EMA
80.46
100-EMA
78.55
200-EMA
72.49
Corporate Actions
| Announcement Date | Purpose | Action | Ex Date |
|---|---|---|---|
| 27 May 2026 | board-meetings | Accounts, Quarterly Results | |
| 14 Feb 2026 | board-meetings | Quarterly Results | |
| 13 Nov 2025 | board-meetings | Quarterly Results | |
| 15 Sept 2025 | agm | ||
| 09 Jul 2025 | egm | ||
| 03 Jul 2025 | egm | ||
| 18 Sept 2024 | agm | ||
| 12 Sept 2023 | agm | ||
| 08 Sept 2022 | agm | ||
| 06 Aug 2022 | egm |
Peer Comparison
No Result Found
Concord Drugs Ltd
Torrent Pharmaceuticals Ltd
Sun Pharmaceutical Industries Ltd
Dr Reddys Laboratories Ltd
Divis Laboratories Ltd
Cipla Ltd
Concord Drugs Ltd About
Concord Drugs is to manufacture licensed drugs based on the formulations approved.
Industry
Pharmaceuticals - Indian - Bulk Drugs & Formln
Founded
1995
Headquarters
CEO
S Nagi Reddy
Employees
Contact
Website
http://www.concorddrugs.in
concorddrugsltd@gmail.com
Phone
91-40-24036379
Location
Survey No 249 Brahmanapally V, Hayathnagar M, Ranga Reddy, Telangana, 501511
Concord Drugs Ltd Company History
| Year | History |
|---|---|
| 1995 |
|
| 2005 |
|
| 2015 |
|
Deals
| Client Name | Deal Type | Order Side | QTY | Avg Price | Date |
|---|---|---|---|---|---|
| PRADEEP KUMAR JAIN | bulk | Sell | 69944 | 54.48 | 04 Jul 2025 |
| GANGA DEVI LOYA | bulk | Buy | 51655 | 53.25 | 03 Jul 2025 |
| PRADEEP KUMAR JAIN | bulk | Sell | 149164 | 53.21 | 03 Jul 2025 |
| GANGA DEVI LOYA | bulk | Sell | 11555 | 53.9 | 03 Jul 2025 |
| GANGA DEVI LOYA | bulk | Buy | 51571 | 38.66 | 30 Jun 2025 |
| LAKSHMI PRASANNA PALLETI | bulk | Sell | 51994 | 44.63 | 15 Jan 2024 |
| MATALIA STOCK BROKING PRIVATE LIMITED | bulk | Sell | 59398 | 57.71 | 29 Dec 2023 |
| MATALIA STOCK BROKING PRIVATE LIMITED | bulk | Buy | 59398 | 58.36 | 29 Dec 2023 |
| LAKHUBHA SOLANKI | bulk | Buy | 51361 | 48.1 | 28 Dec 2023 |
| LAKHUBHA SOLANKI | bulk | Sell | 51361 | 51.46 | 28 Dec 2023 |